Trial Profile
A Study Assessing Diagnostic Accuracy Of 68Ga-PSMA-PET/CT In Patient Selection For Lymphadenectomy In Addition To Salvage Radical Prostatectomy In Locally Recurrent Prostate Cancer After Primary Radiotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 21 Mar 2017 New trial record
- 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium.